Biotechnology · Healthcare
Board Member
2024-06-18–present
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Equibles does not estimate personal net worth.
Get an email with a short summary when Ultragenyx Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.
Get RARE alertsDeborah Dunsire, M.D. is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) since June 18, 2024. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 21, 2024 that Deborah Dunsire, M.D. was appointed Class II Director, effective June 18, 2024. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ultragenyx Pharmaceutical Inc. includes Emil D. Kakkis (CEO and Board Member), Emil Kakkis (CEO and Board Member), Howard Horn (CFO) and 7 others.
“At the Annual Meeting, the Company's stockholders elected the Class II director nominees below to the Company's Board of Directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected.”
2024-06-18–present
Biotechnology · Healthcare
Board Member
2024-06-18–present